Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 28, 2007
Misuse of the well-stirred model of hepatic drug clearance
Jiansong Yang, Masoud Jamei, Karen R Yeo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 22, 2007
Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition
Jiansong Yang, Masoud Jamei, Karen Rowland Yeo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 23, 2009
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - the effect of diltiazem on the time-course of exposure to triazolam
Karen Rowland Yeo, Masoud Jamei, Jiansong Yang, et al.
Clinical Pharmacokinetics
|
February 23, 2010
A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance
Trevor N Johnson, Koen Boussery, Karen Rowland-Yeo, et al.
British Journal of Clinical Pharmacology
|
December 28, 2023
The British Journal of Clinical Pharmacology: The first 50 years
Serge Cremers, Geoffrey T Tucker, Jeffrey K Aronson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 19, 2007
Inactivation of CYP2D6 by methylenedioxymethamphetamine in different recombinant expression systems
Linh M Van, Judith A Hargreaves, Martin S Lennard, et al.
Pharmaceutical Statistics
|
March 18, 2009
Assessing the efficiency of mixed effects modelling in quantifying metabolism based drug-drug interactions: using in vitro data as an aid to assess study power
Trevor N Johnson, Thomas Kerbusch, Barry Jones, et al.
British Journal of Clinical Pharmacology
|
December 15, 2010
Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models
Eleanor J Guest, Karen Rowland-Yeo, Amin Rostami-Hodjegan, et al.
Current Drug Metabolism
|
June 10, 2008
Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions
Jiansong Yang, Mingxiang Liao, Magang Shou, et al.
Journal of Clinical Pharmacology
|
January 25, 2007
Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application
Gemma L Dickinson, Saeed Rezaee, Nicholas J Proctor, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 28, 2007
Misuse of the well-stirred model of hepatic drug clearance
Jiansong Yang, Masoud Jamei, Karen R Yeo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 22, 2007
Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition
Jiansong Yang, Masoud Jamei, Karen Rowland Yeo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 23, 2009
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - the effect of diltiazem on the time-course of exposure to triazolam
Karen Rowland Yeo, Masoud Jamei, Jiansong Yang, et al.
Clinical Pharmacokinetics
|
February 23, 2010
A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance
Trevor N Johnson, Koen Boussery, Karen Rowland-Yeo, et al.
British Journal of Clinical Pharmacology
|
December 28, 2023
The British Journal of Clinical Pharmacology: The first 50 years
Serge Cremers, Geoffrey T Tucker, Jeffrey K Aronson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 19, 2007
Inactivation of CYP2D6 by methylenedioxymethamphetamine in different recombinant expression systems
Linh M Van, Judith A Hargreaves, Martin S Lennard, et al.
Pharmaceutical Statistics
|
March 18, 2009
Assessing the efficiency of mixed effects modelling in quantifying metabolism based drug-drug interactions: using in vitro data as an aid to assess study power
Trevor N Johnson, Thomas Kerbusch, Barry Jones, et al.
British Journal of Clinical Pharmacology
|
December 15, 2010
Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models
Eleanor J Guest, Karen Rowland-Yeo, Amin Rostami-Hodjegan, et al.
Current Drug Metabolism
|
June 10, 2008
Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions
Jiansong Yang, Mingxiang Liao, Magang Shou, et al.
Journal of Clinical Pharmacology
|
January 25, 2007
Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application
Gemma L Dickinson, Saeed Rezaee, Nicholas J Proctor, et al.
Page
of 6